08:00 , Feb 24, 2014 |  BC Week In Review  |  Financial News

SynAffix completes venture financing

SynAffix B.V. , Oss, the Netherlands   Business: Antibodies, Computational chemistry/biology   Date completed: 2/18/14   Type: Venture financing   Raised: Not disclosed   Investors: Aravis Venture; BioGeneration Ventures; MS Ventures; BOM Capital  ...
08:00 , Feb 24, 2014 |  BioCentury  |  Finance

Lean machine for ADCs

Platform companies are notorious for the heavy cash required to turn their platforms into products, but SynAffix B.V. investors are taking a different tack. The syndicate in last week's series A round is hoping for...
01:52 , Feb 20, 2014 |  BC Extra  |  Financial News

ADC play SynAffix raises series A

SynAffix B.V. (Oss, the Netherlands) raised an undisclosed amount in a series A round from new investors Aravis; BioGeneration Ventures; MS Ventures, the strategic corporate fund of the Merck Serono division of Merck KGaA (Xetra:MRK);...